Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12

SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions

Total article views   HTML views PDF downloads Totals
11,554 Dovepress* 9,170+ 1,898 11,068
PubMed Central* 2,384 707 3,091
Totals 11,554 2,605 14,159
*Since 3 July 2019
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar